chevron_leftBack
A
As of 24 April 2025, Allurion Technologies Inc. has a market cap of $13.54M USD, ranking #31792 globally and #4556 in the United States. It ranks #3192 in the Healthcare sector, and #407 in the Medical Devices industry.
Key Stats
Market Cap
$13.54MUSD
Enterprise Value
$85.28MUSD
Revenue (TTM)
$32.11MUSD
EBITDA (TTM)
-$44.2MUSD
Net Income (TTM)
-$26.15MUSD
EBITDA Margin
-138%
Profit Margin
-81%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Shantanu Gaur
open_in_new
Employees
137
Founded
2009
Website
allurion.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.9% | -0.9% | -38% | -27% | -88% | -95% |
Upcoming Earnings
Earnings Date
Tue, May 13
Earnings Time
sunny
Before Open
EPS Estimate
-$1.57
Revenue Estimate
$5.5M
-41% yoy
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
ALUR
Allurion Technologies Inc
ISIN: US02008G2012
Shares Out.:
Shares Outstanding:
5.964M1
Shares Float:
5.18M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
2.27 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Allurion Technologies Inc.
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as offers access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company operates in Spain, France, Turkey, and internationally. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
